02024nam 2200433z- 450 991087089730332120240704(CKB)5840000000523899(oapen)139225(EXLCZ)99584000000052389920240709c2024uuuu -u- -engurmn|---annantxtrdacontentcrdamediacrrdacarrierADP-Ribosylation in PathogensMDPI - Multidisciplinary Digital Publishing Institute20241 online resource3-7258-0985-2 ADP-ribosylation was discovered over 60 years ago, and much of the research focused on bacterial toxins that employed ADP-ribosylation to kill host cells. However, in the last 20 years, the field has identified many cases where host-mediated ADP-ribosylation can either promote or repress pathogenic infections. It is clear that ADP-ribosylation is a key component of the innate immune response in eukaryotes and bacteria, and many of the mechanistic details of how ADP-ribosylation impacts pathogens have yet to be uncovered. In this Special Issue, we have focused on publishing unique reviews and primary research on the topics of pathogens and ADP-ribosylation. We hope that you will enjoy this collection.Mathematics and SciencebicsscBiology, life sciencesbicsscMicrobiology (non-medical)bicsscMedical microbiology and virologybicsscMathematics and ScienceBiology, life sciencesMicrobiology (non-medical)Medical microbiology and virologyLeung Anthony K LedtFehr AnthonyedtAbraham RachyedtLeung Anthony K LothFehr AnthonyothAbraham RachyothBOOK9910870897303321ADP-Ribosylation in Pathogens4175994UNINA